Basic net loss per share of common stock is computed by dividing net loss by the weighted-average number of common stock outstanding during the period. Diluted net loss per share, when applicable, reflects the effect of potentially dilutive securities unless their effect would be antidilutive. When the Company reports a net loss, diluted net loss per share is generally equal to basic net loss per share, as the inclusion of potential common shares would be antidilutive.

The following table presents the calculation of basic and diluted net loss per common share for the periods presented, including adjustments for deemed dividends and discontinued operations, where applicable:


	Fiscal Year Ended
	May 31, 2026		May 31, 2025
Numerator:
Net loss attributable to common stockholders
Continuing operations	$	(49,300)	$	(72,730)
Discontinued operations	(1,020)		—
Adjustment for deemed dividend in connection with equity financings (*)	(113)		$	—
Adjusted net loss used for basic and diluted calculation	$	(50,433)	$	(72,730)
	.
Denominator:
Weighted-average number of common shares, basic and diluted	138,698		138,217

Basic and diluted net loss per share attributable to common stockholders
Continuing operations	$	(0.35)	$	(0.53)
Discontinued operations	(0.01)		—
Net loss per share, basic and diluted	$	(0.36)	$	(0.53)

(*) For the year ended May 31, 2026 (from May 5, 2025 to May 31, 2026), the deemed dividend represents the periodic accretion of the redeemable Series B Preferred Stock's carrying amount to its full redemption value of $5,852, which increases loss available to common stockholders used for the basic and diluted net loss per common share calculation. Refer to Note 13. Temporary Equity – January 2026 Series B Preferred Stock for additional information regarding the January 2026 Series B Preferred Stock.

The following potential shares of common stock were excluded from the calculation of diluted net loss per share for the periods presented because including them would have been antidilutive due to the Company’s net loss position:


			Fiscal Year Ended
Instrument category			May 31, 2026
Options to purchase common stock			9
Restricted stock units and awards			1,017
Warrants for common stock			458
Convertible Series B Preferred Stock			356
B. Riley Promissory Note conversion option			153
Total common stock equivalents			1,993